April 9, 2018, Russian President Vladimir Putin signed Decree No. 151 on awarding of outstanding scientists of the country. "For merits in the field of public health, promoting medical science and long-term conscientious work", the honorary title "Honored Doctor of the Russian Federation" was conferred on Tatyana Slavyanskaya, professor of the Peoples’ Friendship University of Russia. Professor Slavyanskaya works at the Department of Immunology and Allergology, she is Deputy Director of the Institute of Immunophysiology, professor of the International Level of the Department of Allergology and Immunology, Faculty of Refresher Training for medical professionals of the Medical Institute, member of RUDN Dissertation Council D 212.203.26, Vice President of the Union of Allergology and Immunology of the CIS, Secretary General of the World Organization on immunopathology and the Union of Physiological Societies of the CIS, president of "Interastma - CIS".
Professor Slavyanskaya is a member of the specialized Russian and international editorial boards, executive secretary of the “Allergology and Immunology” journal; member of the editorial board of “RUDN Vestnik. Series: Medicine", “Vestnik of the Russian State Medical University", "International Journal on Immunorehabilitation"; Deputy Editor-in-Chief of the Russian version of the journal "Allergy, Clinical Immunology International"; member of the international editorial boards of the "World Allergy Organization Journal" (USA) in English and "Immunopathology, Allergology, Infectology" (Belarus).
Tatyana Slavyanskaya received wide international recognition for her successful scientific and social activities. For the first time in the history of allergology and immunology in Russia and CIS countries (the first and only among Russian scientists) she was elected member of the Board of Directors of the World Allergy Organization and member of the Board of Directors of the Global Asthma Association INTERASMA. She is an Honorary Member of the American Academy of Allergology, Asthma and Immunology, and the American College of Allergology, Asthma and Clinical Immunology; member of the European Academy of Allergy and Clinical Immunology and the International Union of Immunological Societies, the European Federation of Immunological Societies, the European Academy of Allergology, Asthma and Clinical Immunology.
Tatiana Slavyanskaya is the author of more than 450 scientific works in leading Russian and foreign publications. following the results of 2015-2017, she became one of the most fruitful scientists in RUDN, having published more than 46 scientific papers in leading editions of Q1 and Q2, cited in Scopus and Web of Science.
Author of the book "Asthma: Comorbidities, Coexisting Conditions & Differential Diagnosis" in English, published under the auspices of the World Organization of Allergies in Oxford University Press.
One of the initiators of the creation of RUDN Center for Molecular Allergology and Immunology, the first in Russia and the CIS, engaged in innovative developments in the study of the molecular mechanisms of allergic diseases, their molecular diagnostics, and the creation of new methods for precision treatment.
Expert in the field of atopic dermatitis research, which allowed preventing complications in severe cases of the disease.
Based on the research of T.Slavyanskaya in 1983, the method of differential diagnosis of especially dangerous infections based on monoclonal antibodies and staphylococcal infection was developed and introduced into practical public health care (author's certificates for inventions obtained).
For outstanding contribution to the development of world science and international cooperation, Professor Slavyanskaya was awarded numerous honorary international awards, among them Honorary member of the American Academy of Allergology, Asthma and Immunology; Honorary member of the American College of Allergology, Asthma and Immunology; Honorary Professor of Rostov State Medical University; Honorary Professor of the World Organization for Immunopathology; Honorary Diploma and Prize of the President of the World Organization for Allergy - World Allergy Organization, Crystal Cup of WAO; Honorary Diploma of the RF Ministry of Health; Letter of thanks from the RF President.
A chemist from RUDN University has developed a catalyst for the production of eugenol acetate, a substance that destroys the larvae of mosquitoes transmitting dangerous diseases, being a safe chemical for human health.
RUDN soil scientists have revealed a direct correlation between the rate of soil formation of carbon dioxide, called CO2 emissions, and the content of microbial biomass in it. It is known that CO2 emission from soil is mainly conditioned by respiration of soil microorganisms and plant roots. The more CO2 soil emits, the more microbial biomass it usually contains. It was shown that CO2 emission by chernozem of different ecosystems (or different types of land use) correlates with the content of microbial biomass, and most closely with the rate of its microbial respiration. And the soil with good microbial properties has the “best quality”, is more fertile, provides the highest yield of crops and other plant biomass.
A RUDN chemist has synthesized a catalyst for the production of gamma-valerolactone — an energy-intensive “green” biofuel. The catalyst based on zirconium dioxide and zeolite has shown high efficiency in converting the waste of wood plant materials — methyl levulinate — to gamma-valerolactone.